Attovia Therapeutics, Inc. · NASDAQ:ATTO
Sanofi bought 300,000 Attovia Therapeutics, Inc. shares (Form 4)
Traded Aug 6, 2026 · Filed Aug 7, 2026
On Aug 6, 2026, Sanofi (10% owner) bought 300,000 Attovia Therapeutics, Inc. shares at US$17.00 for US$5.1M, leaving 1,082,855 shares. Filed Aug 7, 2026 (Form 4).
- Bought
- 300,000 shares
- Price
- US$17.00
- Value
- US$5.1M
- Holding after
- 1,082,855 shares (held indirectly)
- Trading plan
- No
- Role
- 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | Common Stock | Conversion | 782,855 | 782,855 | Indirect | |
| Aug 6, 2026 | Common Stock | Buy | 300,000 | US$17.00 | 1,082,855 | Indirect |
Source
Related
- Attovia Therapeutics, Inc.
- Sanofi
- Attovia Therapeutics, Inc. shareholders
- Form 4/A · Walsh Colin · Aug 28, 2026
- Form 4/A · Goldman Sachs Asset Management, L.P. · Aug 28, 2026
- Form 4 · Goldman Sachs & Co. LLC · Aug 13, 2026
- Schedule 13G · Deep Track Capital, LP · Aug 12, 2026
- Schedule 13D · Frazier Life Sciences XI, L.P. · Aug 11, 2026